口服硫酸片的有效性和安全性与1-L聚乙烯糖醇加 Askorbate:一个前性的,随机的,内镜盲目的试验
Jin Hwa Park1, Seung Wook Hong2, Sung Wook Hwang2
1Department of Gastroenterology, University of Hanyang College of Medicine, Seoul, South Korea.
Journal of gastroenterology and hepatology
|September 1, 2023
概括
口服硫酸片 (OST) 是有效和安全的结肠镜肠道准备,相当于1-L PEG-A. OST提供了更好的耐受性和更少的泡,提高了患者的体验.
科学领域:
- 胃肠病学 胃肠病学
- 内镜检查是指内镜检查.
- 结肠直肠癌查 结肠直肠癌查
背景情况:
- 低容量肠道制备溶液,如1-L聚乙烯甘醇加酸盐 (PEG-A),旨在提高患者的耐受性.
- 口服硫酸片 (OST) 含有预装的西米西康是一种新的肠道制备剂.
研究的目的:
- 为了比较OST的疗效,安全性和耐受性与1L PEG-A用于结肠镜肠道制备.
- 评估患者报告的结果和与每个制备方法相关的不良事件.
主要方法:
- 一个单中心,前性,随机对照研究,涉及171名患者.
- 使用波士顿肠道制备量表 (BBPS) 和泡泡量表来评估肠道制备功效.
- 安全性和耐受性通过问卷和实验室测试进行评估.
主要成果:
- 与1-L PEG-A.相比,OST显示了不低劣的肠道准备成功率 (95.4% vs 96.4%).
- 使用OST观察到气泡 (0.2对1.9) 和恶心 (14.9%对38.1%) 显著减少.
- 报告说,OST的总体患者满意度更高 (8.1比6.4).
结论:
- OST和1-L PEG-A都是有效和安全的肠道准备选项,用于结肠镜检查.
- 在减少泡负担和改善患者耐受性和满意度方面,OST提供了优势.
- 所有年龄组的研究结果一致,包括65岁及以上的患者.
更多相关视频
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
551
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
551
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
114
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
114
Endoscopic Procedures I: Esophagogastroduodenoscopy
169
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
169
Endoscopic Procedures III: Video Capsule Endoscopy
188
Capsule endoscopy, or wireless or video capsule endoscopy, is a diagnostic procedure for examining the entire gastrointestinal tract. Patients swallow a capsule about the size of a vitamin tablet. The capsule is equipped with a transmitter, a battery, an LED light source, and a color video camera to capture images throughout the gastrointestinal tract. This procedure is particularly useful for diagnosing conditions such as Crohn's disease, ulcerative colitis, tumors, polyps, ulcers,...
188
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110


